Scilex Holding Co
SCLXNasdaqCIK 1820190HealthcareFiscal year ends Dec 31
Reports and events: 215 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2916:07 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-407333 |
| 2026-08-1416:41 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-352464 |
| 2026-08-1217:18 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-347186 |
| 2026-07-2217:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-26-312591 |
| 2026-07-0721:26 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-297859 |
| 2026-07-0606:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-295493 |
| 2026-06-2917:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001193125-26-288677 |
| 2026-06-2616:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-285542 |
| 2026-06-2416:52 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-281213 |
| 2026-05-2017:22 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-232857 |
| 2026-05-1116:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-216921 |
| 2026-05-0513:24 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-205839 |
| 2026-04-3016:55 ET | DEF 14A | Proxy statementPeriod 2026-06-24 | 0001193125-26-197717 |
| 2026-04-2816:58 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-187620 |
| 2026-04-1017:29 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-151455 |
| 2026-03-1312:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-105675 |
| 2026-03-1306:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-104940 |
| 2026-02-2016:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-061371 |
| 2026-02-0317:03 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-035833 |
| 2026-02-0216:07 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-033620 |
| 2025-12-3015:37 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-25-336947 |
| 2025-12-2215:55 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-25-328656 |
| 2025-12-1710:28 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-321928 |
| 2025-12-1621:39 ET | S-1 | Registration statement | 0001193125-25-319720 |
| 2025-12-1216:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-317587 |
| 2025-12-1117:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-25-316239 |
| 2025-12-0516:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-309695 |
| 2025-12-0106:15 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-303037 |
| 2025-11-2417:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-293861 |
| 2025-11-1416:33 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-283153 |
| 2025-11-0716:05 ET | DEF 14A | Proxy statementPeriod 2025-12-11 | 0001193125-25-272322 |
| 2025-11-0413:21 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-264143 |
| 2025-10-3108:56 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-259819 |
| 2025-10-1416:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-238981 |
| 2025-10-0716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-233450 |
| 2025-10-0117:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-226992 |
| 2025-09-2616:10 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-220481 |
| 2025-09-2616:10 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-25-220480 |
| 2025-09-2616:05 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-220446 |
| 2025-09-2616:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-220435 |
| 2025-08-2107:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-184619 |
| 2025-08-1316:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108029 |
| 2025-08-0417:15 ET | S-1 | Registration statement | 0001193125-25-172703 |
| 2025-07-2308:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-162969 |
| 2025-07-2308:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-162938 |
| 2025-06-2317:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-089059 |
| 2025-06-2316:06 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-088971 |
| 2025-06-0416:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-081638 |
| 2025-05-1617:17 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0000950170-25-073612 |
| 2025-05-1416:33 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071517 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.